Recall of Captia EA-D IgG Kit

According to L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), this recall involved a device in France that was produced by Trinity Biotech.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Date
    2009-07-09
  • Event Country
  • Event Source
    ANSM
  • Event Source URL
  • Notes / Alerts
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • Extra notes in the data
  • Action
    The Afssaps was informed on 07/07/2009 by the company Trinity Biotech of the withdrawal of several lots of reagent called Captia EA-D IgG Kit, used for the serology of the Epstein Barr Virus, following a positive control instability. low included in the boxes. The users of this device concerned by this withdrawal, in France, received the attached mail (09/07/2009) (33 KB). The competent European authorities have been informed of this measure by the manufacturer. This information is intended for laboratory managers, health facility managers and local correspondents for reactive surveillance for dissemination to the relevant biology departments.

Device

  • Model / Serial
  • Product Description
    medical_device
  • Manufacturer

Manufacturer